530125 — Samrat Pharmachem Balance Sheet
0.000.00%
Last trade - 00:00- IN₹1.08bn
- IN₹1.17bn
- IN₹2.86bn
- 70
- 55
- 38
- 57
Annual balance sheet for Samrat Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | C2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | PRESS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 25.4 | 147 | 119 | 97.4 | 5.24 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 330 | 436 | 517 | 693 | 565 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 473 | 713 | 991 | 1,026 | 1,034 |
| Net Property, Plant And Equipment | 93.9 | 99.8 | 107 | 107 | 105 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 574 | 846 | 1,166 | 1,217 | 1,215 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 273 | 373 | 532 | 564 | 496 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 278 | 378 | 534 | 567 | 497 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 296 | 468 | 631 | 650 | 718 |
| Total Liabilities & Shareholders' Equity | 574 | 846 | 1,166 | 1,217 | 1,215 |
| Total Common Shares Outstanding |